Browse

Oral Presentation Abstracts

AHNS021

TRENDS IN OPIOD PRESCRIBING PRACTICES AFTER ENDOCRINE SURGERY

Thyroid Cancer

Lauren B Moneta, MD, Enrique Leon, BA, Maisie Shindo, MD

Oregon Health & Science University


AHNS023

A PRACTICAL METHOD TO PREDICT THE SEVERITY OF HYPOCALCEMIA AFTER PARATHYROIDECTOMY FOR PRIMARY HYPERPARATHYROIDISM

Quality of Care and Clinical Pathways

Changxing Liu, MD, PhD, Liyang Tang, MD, Tamara Chambers, MD, Niels Kokot, MD, Uttam Sinha, Dennis Maceri

USC Tina and Rick Caruso Department of Otolaryngology-Head and Neck Surgery, Keck Medicine of USC, University of Southern California


AHNS024

THE POST-THYROIDECTOMY VOICE: THE DISCONNECT BETWEEN PATIENT-PERCEIVED VOICE CHANGES AND OBJECTIVE VOICE MEASURES IN THE FIRST POSTOPERATIVE YEAR

Thyroid Cancer

Heidi Kletzien, MS1, Cameron L Macdonald, PhD2, Jason Orne, PhD3, David O Francis, MD, MS1, Glen Leverson, PhD1, Elizabeth Wendt, MPH1, Rebecca S Sippel, MD1, Nadine P Connor, PhD1

1University of WIsconsin-Madison, 2Qualitative Health Research Consultants, 3Drexel University


AHNS025

STAGING HPV-RELATED OROPHARYNGEAL CANCER: VALIDATION OF AJCC 8 IN A SURGICAL COHORT

Pharynx / Larynx Cancer

Mathew Geltzeiler, MD1, William G Albergotti2, John Gleysteen, MD1, Marnie Bertolet2, Michael Persky, MD2, Neil D Gross, MD3, Ryan Li, MD1, Peter Andersen, MD1, Seungwon Kim, MD2, Robert L Ferris2, Umamaheswar Duvvuri2, Daniel Clayburgh, MD1

1Oregon Health & Science University, 2University of Pittsburgh Medical Center, 3MD Anderson Cancer Center


AHNS026

TOWARDS A TUMOR-SPECIFIC DE-INTENSIFICATION STRATEGY IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS: USING TUMOR IMMUNOPHENOTYPES TO PREDICT PATIENT OUTCOMES

Pharynx / Larynx Cancer

Wesley H Stepp, PhD1, Douglas Farquhar, MD1, Angela Mazul, PhD1, Jose Zevallos, MD2

1University of North Carolina at Chapel Hill, 2Washington University in St. Louis


AHNS027

ABNORMAL MICROVASCULATURE IN LARYNGECTOMY MUCOSAL MARGINS IDENTIFIED ON FROZEN SECTION IS ASSOCIATED WITH INCREASED RISK OF FISTULA

Pharynx / Larynx Cancer

Marianne Abouyared, MD, Darcy Kerr, MD, Brandon Burroway, Zoukaa Sargi, MD, MPH, Jason Leibowitz, MD

University of Miami Miller School of Medicine


AHNS028

OCCULT CONTRALATERAL NODAL DISEASE IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA PATIENTS UNDERGOING PRIMARY TORS WITH BILATERAL NECK DISSECTION

Pharynx / Larynx Cancer

Caitlin McMullen, MD1, Jonathan Garneau, MD2, Emilie Weimar, MD3, Sana Ali, MD4, Joaquim Farinhas, MD, MBA5, Eugene Yu, MD, FRCPC3, Peter Som, MD2, Cathy Sarta, RN4, David Goldstein, MD, MSc, FRCSC3, Susie Su, MSc3, Wei Xu, PhD3, Richard V Smith, MD4, Brett Miles, MD, DDS2, John de Almeida, MD, MSc, FRCSC3

1Moffitt Cancer Center, 2Mount Sinai Hospital, 3Princess Margaret Cancer Center, 4Montefiore Medical Center, 5Florida Hospital - Tampa


AHNS029

THE ROLE OF INTRAVENOUS ACETAMINOPHEN IN POST-OPERATIVE PAIN CONTROL IN HEAD AND NECK CANCER PATIENTS

Pharynx / Larynx Cancer

Erin J Smith, MD, MS1, Jessica Lange, MD2, Cindy Moore, MD1, Lana Jackson, MD1, Isaam Eid, MD3, Jesus Monico, MPH, MS1

1University of Mississippi Medical Center, 2Ear Nose and Throat Specialists, Lexington, Kentucky, 3University of Kansas Medical Center


AHNS030

EFFECT OF TREATMENT MODALITY ON CHRONIC OPIOID USE IN PATIENTS WITH T1/T2 OROPHARYNGEAL CANCER

Pharynx / Larynx Cancer

Craig A Bollig, MD, Jeffrey B Jorgensen, MD

University of Missouri Dept. of Otolaryngology Head and Neck Surgery


AHNS031

BASELINE COGNITION ASSESSMENT AMONG OROPHARYNGEAL CANCER PATIENTS USING PROMIS AND NIH TOOLBOX

Survivorship

Parul Sinha, MBBS, Alex Wong, PhD, Dorina Kallogjeri, MD, MPH, Jay F Piccirillo, MD, FACS

Washington University School of Medicine in St.Louis